JIANGSU GDK BIOTECHNOLOGY CO LTDJIANGSU GDK BIOTECHNOLOGY CO LTDJIANGSU GDK BIOTECHNOLOGY CO LTD

JIANGSU GDK BIOTECHNOLOGY CO LTD

No trades
See on Supercharts

688670 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Jiangsu gdk Biotechnology Co., Ltd. engages in the research and development, production and sale of human vaccines. Its products include freeze-dried human rabies, quadrivalent influenza virus, 23-valent pneumococcal polysaccharide, freeze-dried live attenuated varicella, freeze-dried live attenuated herpes zoster, 13-valent pneumococcal polysaccharide conjugate and recombinant shingles vaccines. The company was founded by Yun De Hou and Jing Zhao on December 29, 2008 and is headquartered in Taizhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
688670 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company